October 2023 in “The Journal of urology/The journal of urology” This study reported no association between higher serum testosterone or dihydrotestosterone levels and the incidence or progression of lower urinary tract symptoms in asymptomatic or symptomatic men in the REDUCE trial, challenging the belief that elevated androgens contribute to these symptoms.
September 2024 in “Health of Man” This study reports that hyperuricemia, the second most common metabolic disease after diabetes, is linked to numerous health issues, especially in males, and recommends lifestyle modifications as an effective management strategy, highlighting the lack of consensus on uric acid thresholds necessitating drug therapy.
September 2024 in “The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy” This study reports that hyperuricemia is a widespread metabolic condition linked with several diseases, including gout and cardiovascular disease, and highlights the importance of lifestyle modifications, particularly in males, for managing this condition efficiently.
August 2023 in “The American Journal of the Medical Sciences” This study found that men with androgenetic alopecia had higher serum uric acid levels and a greater incidence of hyperuricemia compared to those without, but finasteride treatment significantly reduced uric acid levels over six months.
14 citations
,
May 2022 in “Frontiers in Endocrinology” This study found that lower serum testosterone levels were significantly associated with an increased prevalence of kidney stones in men over 40, but not in those aged 20–40.